These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4465730)

  • 21. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 22. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B; Gamba S; Regis G; Turco GL
    Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin antibody production studied quantitatively with a modified radioimmunoassay technique and with radioimmunoelectrophoresis in patients treated with monocomponent (MC) insulin.
    Bruni B; Ricci C; Giolitti A; Osenda M; D'Alberto M; Turco GL
    J Nucl Biol Med; 1973; 17(3):123. PubMed ID: 4746315
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
    Little JA; Lee R; Sebriakova M; Csima A
    Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes of insulin antibodies after monocomponent insulin therapy].
    Takemura Y; Kase T; Hiraiwa M; Hashigami Y; Imai N
    Horumon To Rinsho; 1982 Oct; 30(10):1109-12. PubMed ID: 7165985
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experiences with monocomponent (MC) insulin in the treatment of juvenile diabetes].
    Aronson S; Engleson G
    Lakartidningen; 1976 Nov; 73(46):3982-4. PubMed ID: 790057
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and experimental observations on formalized insulin.
    Katsilambros L
    Isr J Med Sci; 1972 Jun; 8(6):897-8. PubMed ID: 4559430
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical aspects of monocomponent insulins in the treatment of diabetes.
    Vinik AI; Joffe BI; Seftel HC; Distiller LA; Jackson WP
    S Afr Med J; 1976 Apr; 50(15):587-91. PubMed ID: 1265555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monocomponent insulins (author's transl)].
    Rodriguez-Miñón JL
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1215-20. PubMed ID: 409943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical aspects of insulin--antigenicity.
    Schlichtkrull J; Brange J; Christiansen AH; Hallund O; Heding LG; Jorgensen KH
    Diabetes; 1972; 21(2 Suppl):649-56. PubMed ID: 5066240
    [No Abstract]   [Full Text] [Related]  

  • 31. [The insulin treatment and insulin-antigenicity].
    Fankhauser S
    Med Welt; 1975 Oct; 26(40):1831-3. PubMed ID: 1186476
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin treatment does not induce glucagon antibodies.
    Thomsen HG
    Horm Metab Res; 1971 Jan; 3(1):57-8. PubMed ID: 5128330
    [No Abstract]   [Full Text] [Related]  

  • 33. [Serum I-125 insulin IgG binding capacity in diabetic patients on a long-term insulin treatment, with reference to indications for monocomponent insulin therapy].
    Bruni B; Castellazzi R; Osenda M; Papotti G; Turco GL
    Minerva Med; 1974 Mar; 65(20):1071-7. PubMed ID: 4827592
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
    Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
    Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperglycemic hyperosmolar non-ketotic diabetic coma with prolonged insulin-resistnace and extremely high values of insulin-IgG-binding].
    Gamba S; Bruni Bocher K; Hamid S; Bruni B
    Minerva Med; 1975 Oct; 66(72):3785-9. PubMed ID: 1187029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-binding antibody and hormone dosage in non-resistant diabetes.
    Hurn BA; Farrant PC; Young BA; Grahame A
    Postgrad Med J; 1969 Dec; ():Suppl:819+. PubMed ID: 5393006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with monocomponent insulin].
    Fagerberg SE; Gamstedt A
    Lakartidningen; 1976 Nov; 73(47):4097-9. PubMed ID: 994601
    [No Abstract]   [Full Text] [Related]  

  • 40. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
    Kurtz AB; Gray RS; Markanday S; Nabarro JD
    Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.